Related Experiment Video
Updated: Dec 16, 2025

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Mannose-Binding Lectin and Risk of Cardiovascular Events and Mortality in Type 2 Diabetes: A Danish Cohort Study
Anne Gedebjerg1,2, Mette Bjerre3, Alisa Devedzic Kjaergaard4
1Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark aged@clin.au.dk.
Insights
Mannose-binding lectin (MBL) levels show a U-shaped association with cardiovascular events and mortality in type 2 diabetes patients. Both low and high MBL levels increase cardiovascular disease risk.
Area of Science:
- Immunology
- Cardiology
- Endocrinology
Background:
- Mannose-binding lectin (MBL) is implicated in cardiovascular disease (CVD) risk among diabetic individuals.
- The precise nature of the association between MBL and CVD in type 2 diabetes remains unclear.
Purpose of the Study:
- To investigate the relationship between serum MBL levels and MBL expression genotypes with cardiovascular events (CVE) and all-cause mortality in type 2 diabetes.
- To clarify the role of MBL as a potential risk factor for CVD in this patient population.
Main Methods:
- A cohort study involving 7,588 patients with type 2 diabetes.
- Serum MBL levels and MBL expression genotypes were measured and categorized as low, intermediate, or high.
- Cardiovascular events and all-cause mortality were tracked and analyzed using spline and Cox regression models.
Main Results:
- A U-shaped association was observed between serum MBL levels and CVE risk. Low and high MBL levels were associated with increased CVE risk compared to intermediate levels (HRs 1.82 and 1.48, respectively).
- A similar U-shaped association was found for all-cause mortality, though with lower risk estimates.
- MBL expression genotype also showed a U-shaped association with CVE risk, with high-expression genotypes linked to increased risk (HR 1.44).
Conclusions:
- Both serum MBL levels and MBL expression genotypes exhibit a U-shaped association with cardiovascular event risk in individuals with type 2 diabetes.
- These findings suggest that MBL is a significant risk factor for cardiovascular disease in the diabetic population.
Objective:
Mannose-binding lectin (MBL) is linked to risk of cardiovascular disease (CVD) in diabetes, but the nature of the association is unclear. We investigated the association between MBL and the risk of cardiovascular events (CVE) and all-cause mortality in type 2 diabetes.
Research Design And Methods:
In a cohort study of 7,588 patients with type 2 diabetes, we measured serum MBL in 7,305 patients and performed MBL expression genotyping in 3,043 patients. We grouped serum MBL and MBL expression genotypes into three categories: low, intermediate, and high. Outcomes were CVE (myocardial infarction, stroke, coronary revascularization, unstable angina, or cardiovascular death) and all-cause mortality. The association with outcomes was examined by spline and Cox regression analyses.
Results:
Serum MBL and CVE showed a U-shaped association. Compared with the intermediate serum MBL category, the adjusted hazard ratio (HR) for CVE was 1.82 (95% CI 1.34-2.46) for the low-MBL category and 1.48 (95% CI 1.14-1.92) for the high-MBL category. We found a similar U-shaped association for all-cause mortality, but with lower risk estimates. Compared with the intermediate MBL expression genotype, the adjusted HR for CVE was 1.40 (95% CI 0.87-2.25) for the low-expression genotype and 1.44 (95% CI 1.01-2.06) for the high-expression genotype. MBL expression genotype was not associated with all-cause mortality.
Conclusions:
Both serum MBL and MBL expression genotype showed a U-shaped association with CVE risk in individuals with type 2 diabetes. Our findings suggest that serum MBL is a risk factor for CVD in this population.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Coronary Artery Disease I: Introduction
Atherosclerosis III: Management
Diabetes: Symptoms, Diagnosis, and Complications
Psychoneuroimmunology: Diabetes and Cancer
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

